 | E7P | Name: | (2S)-2-amino-4-phosphonobutanoic acid | Formula: | C4 H10 N O5 P | SMILES: | OP(=O)(CCC(C(O)=O)N)O | InChi: | InChI=1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/t3-/m0/s1 | Definition date: | 2017-12-06 | Last modified: | 2024-09-27 | Release date: | 2018-02-07 | Identifier: | (2S)-2-amino-4-phosphonobutanoic acid |
|
 | E87 | Name: | (2R)-3-{[(2R)-2-(decanoylamino)-3-hydroxypropyl]sulfanyl}propane-1,2-diyl ditetradecanoate | Formula: | C44 H85 N O6 S | SMILES: | C(CCCCCCCC)C(NC(CO)CSCC(OC(CCCCCCCCCCCCC)=O)COC(=O)CCCCCCCCCCCCC)=O | InChi: | InChI=1S/C44H85NO6S/c1-4-7-10-13-16-18-20-22-25-28-31-34-43(48)50-37-41(51-44(49)35-32-29-26-23-21-19-17-14-11-8-5-2)39-52-38-40(36-46)45-42(47)33-30-27-24-15-12-9-6-3/h40-41,46H,4-39H2,1-3H3,(H,45,47)/t40-,41-/m1/s1 | Definition date: | 2017-12-07 | Last modified: | 2024-09-27 | Release date: | 2018-05-09 | Identifier: | (2R)-3-{[(2R)-2-(decanoylamino)-3-hydroxypropyl]sulfanyl}propane-1,2-diyl ditetradecanoate |
|
 | E8E | Name: | (2~{S})-4-methyl-~{N}-[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pentanamide | Formula: | C30 H38 N4 O5 | SMILES: | CC(C)C[CH](NC(=O)C=Cc1ccccc1)C(=O)N[CH](C[CH]2CCNC2=O)[CH](O)C(=O)NCc3ccccc3 | InChi: | InChI=1S/C30H38N4O5/c1-20(2)17-25(33-26(35)14-13-21-9-5-3-6-10-21)29(38)34-24(18-23-15-16-31-28(23)37)27(36)30(39)32-19-22-11-7-4-8-12-22/h3-14,20,23-25,27,36H,15-19H2,1-2H3,(H,31,37)(H,32,39)(H,33,35)(H,34,38)/b14-13+/t23-,24-,25-,27+/m0/s1 | Definition date: | 2018-03-01 | Last modified: | 2024-09-27 | Release date: | 2019-03-20 | Identifier: | (2~{S})-4-methyl-~{N}-[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pentanamide |
|
 | E8N | Name: | 1-ethyl-1-methyl-cyclohexane | Formula: | C9 H18 | SMILES: | CCC1(C)CCCCC1 | InChi: | InChI=1S/C9H18/c1-3-9(2)7-5-4-6-8-9/h3-8H2,1-2H3 | Definition date: | 2018-03-04 | Last modified: | 2024-09-27 | Release date: | 2019-03-20 | Identifier: | 1-ethyl-1-methyl-cyclohexane |
|
 | E8U | Name: | (4R)-4-oxidanyl-2-oxidanylidene-heptanedioic acid | Formula: | C7 H10 O6 | SMILES: | O=C(C(=O)O)CC(O)CCC(=O)O | InChi: | InChI=1S/C7H10O6/c8-4(1-2-6(10)11)3-5(9)7(12)13/h4,8H,1-3H2,(H,10,11)(H,12,13)/t4-/m1/s1 | Definition date: | 2012-08-07 | Last modified: | 2024-09-27 | Release date: | 2012-08-24 | Identifier: | (4R)-4-hydroxy-2-oxoheptanedioic acid |
|
 | E8Y | Name: | 4-[3-(trifluoromethyl)anilino]-1,3-dihydro-2H-isoindole-2-carbonitrile | Formula: | C16 H12 F3 N3 | SMILES: | FC(F)(F)c1cc(ccc1)Nc1cccc2CN(Cc21)C#N | InChi: | InChI=1S/C16H12F3N3/c17-16(18,19)12-4-2-5-13(7-12)21-15-6-1-3-11-8-22(10-20)9-14(11)15/h1-7,21H,8-9H2 | Definition date: | 2021-12-06 | Last modified: | 2024-09-27 | Release date: | 2023-06-14 | Identifier: | 4-[3-(trifluoromethyl)anilino]-1,3-dihydro-2H-isoindole-2-carbonitrile |
|
 | EO2 | Name: | 4,5-Dehydro-L-leucine | Formula: | C6 H11 N O2 | SMILES: | CC(=C)C[CH](N)C(O)=O | InChi: | InChI=1S/C6H11NO2/c1-4(2)3-5(7)6(8)9/h5H,1,3,7H2,2H3,(H,8,9)/t5-/m0/s1 | Definition date: | 2018-04-03 | Last modified: | 2024-09-27 | Release date: | 2018-10-17 | Identifier: | (2~{S})-2-azanyl-4-methyl-pent-4-enoic acid |
|
 | EO6 | Name: | (1R,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C23 H37 N5 O8 S | SMILES: | O=C1NCCC1CC(NC(=O)C(CC(C)C)NC(=O)OC1CC2(CCN(CC2)C#N)C1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C23H37N5O8S/c1-14(2)9-17(27-22(32)36-16-11-23(12-16)4-7-28(13-24)8-5-23)20(30)26-18(21(31)37(33,34)35)10-15-3-6-25-19(15)29/h14-18,21,31H,3-12H2,1-2H3,(H,25,29)(H,26,30)(H,27,32)(H,33,34,35)/t15-,17-,18-,21+/m0/s1 | Definition date: | 2021-12-10 | Last modified: | 2024-09-27 | Release date: | 2021-12-22 | Identifier: | (1R,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | EO9 | Name: | [(1S)-1-[(2,6-difluorophenyl)carbonylamino]ethyl]-trihydroxy-boron | Formula: | C9 H11 B F2 N O4 | SMILES: | C[CH](NC(=O)c1c(F)cccc1F)[B-](O)(O)O | InChi: | InChI=1S/C9H11BF2NO4/c1-5(10(15,16)17)13-9(14)8-6(11)3-2-4-7(8)12/h2-5,15-17H,1H3,(H,13,14)/q-1/t5-/m1/s1 | Definition date: | 2010-12-15 | Last modified: | 2024-09-27 | Identifier: | [(1S)-1-[(2,6-difluorophenyl)carbonylamino]ethyl]-trihydroxy-boron |
|
 | EOE | Name: | beta3-proline | Formula: | C6 H11 N O2 | SMILES: | OC(=O)C[CH]1CCCN1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-5-2-1-3-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1 | Definition date: | 2018-04-03 | Last modified: | 2024-09-27 | Release date: | 2019-04-10 | Identifier: | 2-[(2~{S})-pyrrolidin-2-yl]ethanoic acid |
|
 | EOF | Name: | (2~{S})-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pentanamide | Formula: | C22 H29 N3 O4 | SMILES: | CC(C)C[CH](NC(=O)C=Cc1ccccc1)C(=O)N[CH](C[CH]2CCNC2=O)C=O | InChi: | InChI=1S/C22H29N3O4/c1-15(2)12-19(25-20(27)9-8-16-6-4-3-5-7-16)22(29)24-18(14-26)13-17-10-11-23-21(17)28/h3-9,14-15,17-19H,10-13H2,1-2H3,(H,23,28)(H,24,29)(H,25,27)/b9-8+/t17-,18-,19-/m0/s1 | Definition date: | 2020-01-17 | Last modified: | 2024-09-27 | Release date: | 2020-05-27 | Identifier: | (2~{S})-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pentanamide |
|
 | EOH | Name: | ETHANOL | Formula: | C2 H6 O | SMILES: | OCC | InChi: | InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | ethanol |
|
 | EP0 | Name: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline | Formula: | C17 H28 N2 O7 | SMILES: | O=C(O)C1N(C(=O)C(NC(=O)CC(O)C(=O)OCC)C(C)CC)CCC1 | InChi: | InChI=1S/C17H28N2O7/c1-4-10(3)14(15(22)19-8-6-7-11(19)16(23)24)18-13(21)9-12(20)17(25)26-5-2/h10-12,14,20H,4-9H2,1-3H3,(H,18,21)(H,23,24)/t10-,11-,12+,14-/m0/s1 | Synonyms: | epoxy succinyl inhibitor | Definition date: | 2008-03-25 | Last modified: | 2024-09-27 | Identifier: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline |
|
 | EP9 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-4-oxobutan-2-yl]-L-leucinamide | Formula: | C30 H41 N3 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(Cc2ccc(O)cc2)C(O)C=O)CC(C)C)CC(C)C | InChi: | InChI=1S/C30H41N3O7/c1-19(2)14-25(28(37)31-24(27(36)17-34)16-21-10-12-23(35)13-11-21)32-29(38)26(15-20(3)4)33-30(39)40-18-22-8-6-5-7-9-22/h5-13,17,19-20,24-27,35-36H,14-16,18H2,1-4H3,(H,31,37)(H,32,38)(H,33,39)/t24-,25-,26-,27+/m0/s1 | Synonyms: | Z-Leu-Leu-TyrCOCHO, hemiketal form | Definition date: | 2011-04-19 | Last modified: | 2024-09-27 | Identifier: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-4-oxobutan-2-yl]-L-leucinamide |
|
 | EPE | Name: | 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID | Formula: | C8 H18 N2 O4 S | SMILES: | O=S(=O)(O)CCN1CCN(CCO)CC1 | InChi: | InChI=1S/C8H18N2O4S/c11-7-5-9-1-3-10(4-2-9)6-8-15(12,13)14/h11H,1-8H2,(H,12,13,14) | Synonyms: | HEPES | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid |
|
 | EPG | Name: | (2R)-oxiran-2-ylmethyl alpha-D-glucopyranoside | Formula: | C9 H16 O7 | SMILES: | O(CC1OC1)C2OC(C(O)C(O)C2O)CO | InChi: | InChI=1S/C9H16O7/c10-1-5-6(11)7(12)8(13)9(16-5)15-3-4-2-14-4/h4-13H,1-3H2/t4-,5-,6-,7+,8-,9+/m1/s1 | Synonyms: | 2-HYDROXYMETHYL-6-OXIRANYLMETHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL | Definition date: | 2002-11-28 | Last modified: | 2024-09-27 | Identifier: | (2R)-oxiran-2-ylmethyl alpha-D-glucopyranoside |
|
 | EPN | Name: | 3-(4-NITRO-PHENOXY)-PROPAN-1-OL | Formula: | C9 H11 N O4 | SMILES: | [O-][N+](=O)c1ccc(OCCCO)cc1 | InChi: | InChI=1S/C9H11NO4/c11-6-1-7-14-9-4-2-8(3-5-9)10(12)13/h2-5,11H,1,6-7H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-(4-nitrophenoxy)propan-1-ol |
|
 | EPZ | Name: | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid | Formula: | C20 H31 N3 O19 P2 | SMILES: | O=C1C=CN(C(=O)N1)C2OC(C(O)C2O)COP(=O)(OP(=O)(OC3OC(C(O)C(OC(C(=O)O)C)C3NC(=O)C)CO)O)O | InChi: | InChI=1S/C20H31N3O19P2/c1-7(18(30)31)38-16-12(21-8(2)25)19(40-9(5-24)14(16)28)41-44(35,36)42-43(33,34)37-6-10-13(27)15(29)17(39-10)23-4-3-11(26)22-20(23)32/h3-4,7,9-10,12-17,19,24,27-29H,5-6H2,1-2H3,(H,21,25)(H,30,31)(H,33,34)(H,35,36)(H,22,26,32)/t7-,9-,10-,12-,13-,14-,15-,16-,17-,19-/m1/s1 | Definition date: | 2011-07-12 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid (non-preferred name) |
|
 | EQF | Name: | (3~{R},4~{S})-1-[[6-chloranyl-5-(trifluoromethyl)pyridin-2-yl]amino]-3,4-dimethyl-pyrrolidine-2,5-dione | Formula: | C12 H11 Cl F3 N3 O2 | SMILES: | C[CH]1[CH](C)C(=O)N(Nc2ccc(c(Cl)n2)C(F)(F)F)C1=O | InChi: | InChI=1S/C12H11ClF3N3O2/c1-5-6(2)11(21)19(10(5)20)18-8-4-3-7(9(13)17-8)12(14,15)16/h3-6H,1-2H3,(H,17,18)/t5-,6+ | Definition date: | 2020-01-21 | Last modified: | 2024-09-27 | Release date: | 2021-06-23 | Identifier: | (3~{R},4~{S})-1-[[6-chloranyl-5-(trifluoromethyl)pyridin-2-yl]amino]-3,4-dimethyl-pyrrolidine-2,5-dione |
|
 | EQS | Name: | (1S,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C23 H37 N5 O8 S | SMILES: | O=C1NCCC1CC(NC(=O)C(CC(C)C)NC(=O)OC1CC2(CCN(CC2)C#N)C1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C23H37N5O8S/c1-14(2)9-17(27-22(32)36-16-11-23(12-16)4-7-28(13-24)8-5-23)20(30)26-18(21(31)37(33,34)35)10-15-3-6-25-19(15)29/h14-18,21,31H,3-12H2,1-2H3,(H,25,29)(H,26,30)(H,27,32)(H,33,34,35)/t15-,17-,18-,21-/m0/s1 | Definition date: | 2021-12-10 | Last modified: | 2024-09-27 | Release date: | 2021-12-22 | Identifier: | (1S,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | ERC | Name: | 8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-one | Formula: | C23 H28 N2 O5 S | SMILES: | O=C3C=Cc1c(c(O)ccc1C(O)CNCCc2ccc(OCCCS)c(OC)c2)N3 | InChi: | InChI=1S/C23H28N2O5S/c1-29-21-13-15(3-7-20(21)30-11-2-12-31)9-10-24-14-19(27)16-4-6-18(26)23-17(16)5-8-22(28)25-23/h3-8,13,19,24,26-27,31H,2,9-12,14H2,1H3,(H,25,28)/t19-/m0/s1 | Definition date: | 2010-10-25 | Last modified: | 2024-09-27 | Identifier: | 8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-one |
|
 | ERE | Name: | 4-epi-vancosamine | Formula: | C7 H15 N O3 | SMILES: | OC1OC(C(O)C(N)(C)C1)C | InChi: | InChI=1S/C7H15NO3/c1-4-6(10)7(2,8)3-5(9)11-4/h4-6,9-10H,3,8H2,1-2H3/t4-,5+,6-,7-/m0/s1 | Synonyms: | (1R,3S,4R,5S)-3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranose | Definition date: | 2010-08-12 | Last modified: | 2024-09-27 | Identifier: | 3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranose |
|
 | ERF | Name: | phosphonooxy-[(4-thiophen-3-yl-1,2,3-triazol-1-yl)methyl]borinic acid | Formula: | C7 H9 B N3 O5 P S | SMILES: | OB(Cn1cc(nn1)c2cscc2)O[P](O)(O)=O | InChi: | InChI=1S/C7H9BN3O5PS/c12-8(16-17(13,14)15)5-11-3-7(9-10-11)6-1-2-18-4-6/h1-4,12H,5H2,(H2,13,14,15) | Definition date: | 2019-08-16 | Last modified: | 2024-09-27 | Release date: | 2020-06-24 | Identifier: | phosphonooxy-[(4-thiophen-3-yl-1,2,3-triazol-1-yl)methyl]borinic acid |
|
 | ESB | Name: | 3-[(3E)-3-(ETHYLIMINO)-4-HYDROXY-6-OXOCYCLOHEXA-1,4-DIEN-1-YL]-L-ALANINE | Formula: | C11 H14 N2 O4 | SMILES: | O=C1C=C(O)/C(=N/CC)C=C1CC(C(=O)O)N | InChi: | InChI=1S/C11H14N2O4/c1-2-13-8-4-6(3-7(12)11(16)17)9(14)5-10(8)15/h4-5,7,15H,2-3,12H2,1H3,(H,16,17)/b13-8+/t7-/m0/s1 | Definition date: | 2008-04-03 | Last modified: | 2024-09-27 | Identifier: | 3-[(3E)-3-(ethylimino)-4-hydroxy-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
 | ESC | Name: | 2-AMINO-4-ETHYL SULFANYL BUTYRIC ACID | Formula: | C6 H13 N O2 S | SMILES: | O=C(O)C(N)CCSCC | InChi: | InChI=1S/C6H13NO2S/c1-2-10-4-3-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-09-27 | Last modified: | 2024-09-27 | Identifier: | S-ethyl-L-homocysteine |
|